Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Paired-like homeodomain protein ESXR1 possesses a cleavable C-terminal region that inhibits cyclin degradation

Abstract

The eukaryotic cell cycle is regulated by sequential activation and inactivation of cyclin–cyclin-dependent kinase (Cdk) complexes. In this work, we screened human cDNAs that can rescue yeast Saccharomyces cerevisiae from lethality caused by ectopic expression of human cyclin E and isolated a cDNA encoding ESXR1, a paired-like homeodomain-containing protein with a unique C-terminal proline-rich repeat region. In adult tissues, ESXR1 is primarily expressed in the testis. We demonstrate that ESXR1 prevents degradation of ubiquitinated cyclins in human cells. Accordingly, elevation of ESXR1 level results in accumulation of cyclin A and cyclin B1 and thereby provokes M-phase arrest. In human cells, the 65-kDa full-length ESXR1 protein is capable of proteolytically processing into N-terminal 45-kDa and C-terminal 20-kDa fragments. The C-terminal fragment, containing a proline-rich repeat region, is localized to the cytoplasm and displays the ability to inhibit cyclin degradation. In contrast, the N-terminal fragment, containing a paired-like homeodomain, is localized exclusively in the nucleus, suggesting that it plays a role in transcription. Our results indicate that proteolytic processing of ESXR1 plays a role in concerted regulation of the cell cycle and transcription in human cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11

Similar content being viewed by others

References

  • Aberle H, Bauer A, Stappert J, Kispert A and Kemler R . (1997). EMBO J., 16, 3797–3804.

  • Ashizawa S, Nishizawa H, Yamada M, Higashi H, Kondo T, Ozawa H, Kakita A and Hatakeyama M . (2001). J. Biol. Chem., 276, 11362–11370.

  • Azam M, Lee C, Strehlow I and Schindler C . (1997). Immunity, 6, 691–701.

  • Brandeis M and Hunt T . (1996). EMBO J., 15, 5280–5289.

  • Branford WW, Zhao GQ, Valerius MT, Weinstein M, Birkenmeier EH, Rowe LB and Potter SS . (1997). Mech. Dev., 65, 87–98.

  • Chang DC, Xu N and Luo KQ . (2003). J. Biol. Chem., 278, 37865–37873.

  • den Elzen N and Pines J . (2001). J. Cell Biol., 153, 121–136.

  • DeSalle LM and Pagano M . (2001). FEBS Lett., 490, 179–189.

  • Dulic V, Lees E and Reed SI . (1992). Science, 257, 1958–1961.

  • D'Urso G, Marraccino RL, Marshak DR and Roberts JM . (1990). Science, 250, 786–791.

  • Featherstone C and Russell P . (1991). Nature, 349, 808–811.

  • Fohn LE and Behringer RR . (2001). Genomics, 74, 105–108.

  • Furuno N, den Elzen N and Pines J . (1999). J. Cell Biol., 147, 295–306.

  • Glotzer M, Murray AW and Kirschner MW . (1991). Nature, 349, 132–138.

  • Guadagno TM and Newport JW . (1996). Cell, 84, 73–82.

  • King RW, Deshaies RJ, Peters JM and Kirschner MW . (1996). Science, 274, 1652–1659.

  • Lew DJ, Dulic V and Reed SI . (1991). Cell, 66, 1197–1206.

  • Li Y, Lemaire P and Behringer RR . (1997). Dev. Biol., 188, 85–95.

  • Lundgren K, Walworth N, Booher R, Dembski M, Kirschner M and Beach D . (1991). Cell, 64, 1111–1122.

  • Millar JB, McGowan CH, Lenaers G, Jones R and Russell P . (1991). EMBO J., 10, 4301–4309.

  • Morgan DO . (1995). Nature, 374, 131–134.

  • Mumberg D, Müller R and Funk M . (1994). Nucleic Acids Res., 22, 5767–5768.

  • Naumann M, Nieters A, Hatada EN and Scheidereit C . (1993). Oncogene, 8, 2275–2281.

  • Ninomiya-Tsuji J, Nomoto S, Yasuda H, Reed SI and Matsumoto K . (1991). Proc. Natl. Acad. Sci. USA, 88, 9006–9010.

  • Nurse P . (2000). Cell, 100, 71–78.

  • Sette C, Barchi M, Bianchini A, Conti M, Rossi P and Geremia R . (1999). J. Biol. Chem., 274, 33571–33579.

  • Sherr CJ . (1994). Cell, 79, 551–555.

  • Solomon MJ, Glotzer M, Lee TH, Philippe M and Kirschner MW . (1990). Cell, 63, 1013–1024.

  • Su TT . (2001). Curr. Biol., 11, 467–469.

  • Tedesco D, Lukas J and Reed SI . (2002). Genes Dev., 16, 2946–2957.

  • Weinberg RA . (1995). Cell, 81, 323–330.

  • Yan YT, Stein SM, Ding J, Shen MM and Abate-Shen C . (2000). Mol. Cell. Biol., 20, 661–671.

Download references

Acknowledgements

We thank Dr Kunihiro Matsumoto and Dr Hideyoshi Yokosawa for cDNAs. We also thank Dr Chizuko Umehara and Takao Ueno for technical assistance. This work was supported by grants from the Human Frontier Science Program (HFSP), the Ministry of Education, Science, Sports, and Culture of Japan, and the Virtual Research Institute of Aging of Nippon Boehringer Ingelheim.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masanori Hatakeyama.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ozawa, H., Ashizawa, S., Naito, M. et al. Paired-like homeodomain protein ESXR1 possesses a cleavable C-terminal region that inhibits cyclin degradation. Oncogene 23, 6590–6602 (2004). https://doi.org/10.1038/sj.onc.1207884

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207884

Keywords

This article is cited by

Search

Quick links